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Ever since the initial description of ax-proteinase inhibitor I (alPI),  2 the role of this 
plasma  glycoprotein  and  its  allelic  polymorphism  (1)  in  disease  and  in  healthy 
physiology has been the subject of much investigation (2).  alPI inactivates a number 
of serine proteinases, including  granulocyte elastase (3), and thus affords protection 
from the  connective tissue  degradation  mediated  by this  class  of proteinases.  The 
genetic deficiency of alPI in individuals with a  Pi ZZ phenotype is associated with 
premature development of pulmonary emphysema (4, 5) and other disorders, such as 
childhood cirrhosis (6). Lung and liver are exposed to both circulating alPI and serine 
proteinases from granules of polymorphonuclear leukocytes. Because an imbalance in 
the ratio between alPI and proteinase may contribute to the development of destruc- 
tive lung diseases, proteinases have been implicated in the pathogenesis of pulmolaary 
emphysema (7). 
Both  macrophages  and  polymorphonuclear  leukocytes  have  been  implicated  in 
disruption of the alPI-proteinase balance. The production of reactive oxygen species 
(8,  9)  by  phagocytosing cells  (10)  and  exposure  to  cigarette  smoke  (11)  has  been 
suggested  as  a  mechanism  for  inactivating  alPI  and  inducing  lung  damage.  In 
addition  to  their  phagocytic  activity,  stimulated  macrophages  actively  secrete  a 
number of proteinases, including the metalloproteinases collagenase (12) and elastase 
(13-15). 
In this report we demonstrate a new mechanism for alteration of the alPI-proteinase 
balance. We have found that the purified form of macrophage elastase catalytically 
degrades and inactivates alPI so that it no longer inhibits the elastinolytic activity of 
granulocyte elastase. 
Materials and Methods 
Enzymes.  Macrophage elastase (ME) was purified from medium conditioned by thioglycol- 
late-elicited  mouse peritoneal macrophages as previously described (15). The preparation was 
purified 3,900-fold  and had a  5,400  U/mg sp act, where  1 U  of elastase degraded  1 pg of 
insoluble  elastin/h at 37°C.  ME migrated as a single band at an apparent molecular weight 
(Mr) of 22,000 on both reducing and nonreducing sodium dodecyl sulfate (SDS)-polyacrylamide 
electrophoretic gels. 
Human  granulocyte elastase  (HGE)  (16),  a  gift  of A. J.  Barrett  (Strangeways  Research 
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Laboratory, Cambridge, England), had a  35,000  U/mg sp act. On reducing SDS-polyacryl- 
amide gels, the major band of HGE migrated at M, 27,000. 
Inhibitors.  Human alPI, a gift of C. Glaser (Institutes of Medical Sciences, San Francisco, 
Calif.), was purified from human Pi MM plasma by a modification of the method of Glaser et 
al. (17);  Cibacron blue (Ciba-Geigy Corp., Ardsley, N. Y.)-Sepharose 4B was used instead of 
concanavalin A  for  the  removal  of albumin.  On  reducing  SDS-polyacrylamide gels,  alPI 
migrated at M, 58,000 either as a  single band or as a  double band  (an artifact of Laemmli 
system gels). It exhibited >95% inhibitory activity against trypsin. 
Human  a2-macroglobulin (a2M)  was purified from  fresh haptoglobin type  1-1  serum  by 
Cibacron blue-Sepharose 4B affinity chromatography (18). The purified a2M gave a single line 
of identity against rabbit anti-human whole serum (Bio-Rad Laboratories, Richmond, Calif.) 
and rabbit anti-human azM (Bio-Rad Laboratories). It was >95% active when calibrated by 
inhibition of active site-titrated trypsin (Worthington Biochemical Corp., Freehold, N.J.). a~M 
migrated as a single band at Mr 725,000  on pore-limit polyacrylamide gels (19).  On reducing 
SDS-polyacrylamide gels, a2M migrated as a major band at M, 185,000  and a series of minor 
bands at Mr 139,000  and 64,000-68,000.  These minor bands were heat-cleavage products (19, 
20) and consisted of < 1% of the total a2M protein. Another band at Mr 85,000 was the result 
of interaction of proteinases with a~M. 
Methoxy-succinyl-alanyl-alanyl-prolyl-valyl-chloromethyl  ketone (SPCK), a  specific active 
site-directed inhibitor of granulocyte elastase (21), was a gift of J. Powers (Georgia Institute of 
Technology, Athens, Ga.). 
Electrophoresis.  SDS-polyacrylamide gel  electrophoresis was  carried  out  according  to  a 
modification of the method of Laemmli (22).  The samples were resolved on a  linear 7-18% 
polyacrylamide gradient and reduced by boiling in 0.5% 2-mercaptoethanol (Sigma Chemical 
Co., St. Louis, Mo.). After electrophoresis, gels were fixed in 45% trichloroacetic acid for 30 min 
at 4°C, then stained in 0.05%  Coomassie blue R250  (Sigma). The addition of 0.02% fluores- 
camine  (5  mg/ml  in  acetone)  (Fluram;  Roche  Diagnostics Div.,  Hoffman  La  Roche  Inc., 
Nutley, N. J.) to some of the electrophoresis samples after boiling allowed protein bands to be 
observed by their fluorescence when irradiated with 366-nm ultraviolet light during and after 
electrophoresis. Molecular weight markers were included in all gels. The marker mixture (Bio- 
Rad  Laboratories)  was  composed  of myosin  (Mr  200,000),  fl-galactosidase  (Mr  130,000), 
phosphorylase B  (Mr  94,000),  bovine serum  albumin  (Mr 68,000),  ovalbumin  (Mr  43,000), 
carbonic anhydrase  (Mr  30,000),  soybean  trypsin inhibitor  (Mr  21,000),  and  lysozyme (Mr 
14,300).  Some gels included oxidized insulin B chain (Mr 3,600)  (Sigma Chemical Co.). 
Elastase Assay.  Elastinolytic activity was measured by determining the amount of soluble 
radioactivity released from insoluble [3H]elastin in the absence of SDS (14). Reaction mixtures 
were stabilized with 20 #g bovine serum albumin (Sigma Chemical Co.) and were incubated 
with 200 #g [aH]elastin in 100 mM Tris-HCl, pH 8.0, which contained 5 mM CaC12 in a final 
volume of 300 #1. At the end of incubation, the reaction mixtures were centrifuged for 3 rain in 
a Beckman Microfuge B  (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.) and the 
radioactivity in 200 #1 of super.nate was determined by liquid scintillation spectrometry. 
Incubation of ME with alPl.  ME was incubated at 37°C with aiPI (ME:aIPI, 1:100 or 1:3.7 
wt:wt), 18 mM Tris-HCl, pH 8.0, which contained 10 mM CaCI2 and 30 mM NaC1,  for times 
varying from 30 s to 8 h. When proteinase inhibitors were included (either a2M:ME,  1:1 mol: 
mol; or 30 mM EDTA) they were preincubated with ME for 30 min at room temperature. The 
ME-dependent reactions were stopped by the addition of EDTA to a final concentration of 30 
mM. 
Incubation of HGE with aiPI.  HGE was incubated at 37°C with alPI (HGE:t~IPI, 1:5 wt:wt 
or  1:2.6 mol:mol) in  18 mM Tris-HCl, pH 8.0,  which contained  10 mM CaC12 and 30 mM 
NaC1. When an inhibitor of HGE was included (SPCK:HGE, 6:1 mol:mol) it was preincubated 
with HGE for 30 min at room temperature. HGE-axPI reactions were stopped by the addition 
of SPCK (SPCK:HGE, 6:1 mol:mol), and the mixtures were analyzed on gels. 
a~PI degraded by ME was assayed for residual inhibitory activity toward HGE.  ME-a~PI 
reactions were stopped with 30 mM EDTA, and then aliquots (0.28 #g of alPI) were incubated 
with  HGE  (0.15  #g)  for  30  min  at  room  temperature and  the elastinolytic activity of the 
mixture was determined by means of the aH-elastin assay. MICHAEL J.  BANDA, ELIZABETH j.  CLARK, AND  ZENA WERB  1565 
Incubation of ME with HGE and alPI.  etlPI was incubated with HGE (5:1, wt:wt) for 30 rain 
at  room  temperature  and  then  incubated  with  ME  (axPI:HGE:ME,  5:1:0.01  wt:wt:wt). 
Reactions were stopped by the addition of EDTA at a  final concentration of 30 raM. 
Results 
Limited Proteolysis ofcttPI by ME.  Reaction mixtures of ME-alPI were examined by 
SDS-polyacrylamide gel electrophoresis (Fig.  1). Coomassie blue staining of the gels 
demonstrated that purified alPI  migrated as a  band  at Mr 58,000 even after a  6-h 
sham incubation. When ME and alPI were incubated for 6 h at a  1:100 (wt:wt) ratio, 
the t~xPI band migrated faster, at Mr 53,000-54,000. Staining of the reaction mixtures 
with fluorescamine revealed an M~ 4,000-5,000 fragment (data not shown) that was 
always associated with ME-degraded aaPI. 
In the ME-alPI reaction mixtures, there was no indication of the formation of a 
higher  molecular  weight  proteinase-inhibitor  complex stable  in  SDS.  This  distin- 
guishes the degradation ofaxPI by ME from that attributed to some serine proteinases 
(23,  24).  When  alPI  was  incubated  with  an  excess  of pancreatic  elastase,  a  low 
percentage  of axPI  was  degraded  only  after  the  formation  of a  stable  Mr  78,000 
intermediate (23). However, in the present study, ME recognized alPI as an acceptable 
substrate and degraded it catalytically. 
Inhibition of Proteolysis of ctlPI by ME.  ME is a  metalloproteinase that is inhibited 
by chelators of divalent cations, such as EDTA.  Preincubation of ME with  EDTA 
prevented  degradation  of aiPI  (Fig.  1).  The  inhibition  of ME  by  stoichiometric 
amounts of the endopeptidase inhibitor,  a2M,  also  prevented degradation of ctlPI. 
The  result  of the  interaction of a2M  with  ME  was  the cleavage of an  Mr  85,000 
Fro.  1.  Degradation of alPI by ME and the effect of EDTA and auM on the reaction. The samples 
in each lane were incubated at pH 8.0 for 6 h at 37°C in  18 mM Tris-HCl, 10 mM CaClu, and 30 
mM NaC1 that contained (a) 3/tg aaPl, 0.03/tg ME, and 30 mM EDTA; (b) 3 #g alPI, 1/tg a2M, 
and 0.03 #g ME (-1:1  mol:mol ME:a2M); (c) 3/~g alPI and 0.03/.tg  ME; (d) 3/.tg alPI; or (e)  1 
/tg  auM.  Samples were  run  on  an  SDS-polyacrylamide gradient  gel  (7-18%)  under  reducing 
conditions and stained with Coomassie blue. Molecular weight standards (Mr ×  10  -a) are indicated 
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fragment from a2M. The effect of these inhibitors was consistent with the inhibitor 
profile of purified ME when elastin is used as a substrate. 
Loss of Inhibitory Activity  of alPI Degraded by  ME.  To  determine  whether  alPI 
retained inhibitory activity after being degraded by ME, aliquots of ME-aIPI reaction 
mixtures were  incubated  with  HGE,  and  elastinolytic activity was  determined  by 
means  of the  aH-elastin  assay.  Direct  elastinolytic activity by ME  was  eliminated 
before mixing with HGE by the addition of EDTA to the ME-aIPI reaction mixtures 
at the end of the incubation times indicated in Fig. 2. This inhibited the metallopro- 
teinase activity of ME but did not inhibit the serine proteinase activity of HGE. Fig. 
3  indicates that  only the intact alPI was  inhibitory and  that  the loss  of inhibitory 
capacity was proportional to the degree of degradation by ME. Degradation and the 
loss of inhibitory capacity were evident after only a 30-s incubation of alPI with ME. 
Effect  of ME on HGE-ctlPI Complexes.  In  contrast  to  ME,  HGE  forms  a  typical 
proteinase-inhibitor complex with  cqPI during incubation  (Fig.  4).  The HGE-aaPI 
inhibitor complex requires an  unoccupied HGE active site.  When  excess SPCK, a 
FIO.  2.  Time-course of ME degradation of alPI. Each lane was loaded with aliquots of ME:oqPI 
(1:100  wt:wt) reaction mixtures incubated in  18 mM Tris-HCl,  10 mM CaCI2, and 20 mM NaCI, 
pH 8.0,  at  37°C for:  (a)  0  s;  Co)  30 s;  (c) 0.5 h;  (d)  2 h;  (e)  4 h;  or (t)  8 h  (lane f contained less 
protein  than  lanes a-e).  Electrophoresis conditions were  identical  to  those in  Fig.  1.  Molecular 
weight standards (M, ×  10  -s) are indicated at the left. 
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FIG.  3.  Inhibitory activity of ME-degraded alPI.  Reaction  mixtures of ME:axPI  (1:100  wt:wt) 
were  assayed  for  residual  OtlPI inhibitory activity  against  HGE,  as  described in  Materials  and 
Methods.  The  zero-time  activity  is  that  of unreacted  alPI  normalized  to  100%. The  reaction 
mixtures were identical to those analyzed by electrophoresis in Fig. 2. MICHAEL J.  BANDA, ELIZABETH J.  CLARK, AND ZENA WERB  1567 
Fro. 4.  Interaction  of HGE  with  alPI and  the effect of ME  on  the  HGE-alPI complex.  All 
reactions were carried out in  18 mM Tris-HCl, 10 mM 12aC12, 30 mM NaCI, pH 8.0, at 37°C. 
Experimental  details are described  in  Materials and Methods.  Lane (a) contained 0.5 /~g HGE 
(inactivated with 0.2 pg SPCK) and 1.75/xg alPI incubated for 15 h. Lanes (b-d) contained 0.5 ~ag 
HGE and 1.75/~g eqPI incubated for (b) 0 h; (c) 0.5 h; or (d)  15 h. Lanes (e-h) contained 0.5/zg 
HGE and 1.75/tg alPI incubated at room temperature for 0.5 h before the addition of  0.018 p.g ME 
and further  incubation at 37°12 for (e)  10 s;  (0  2 h; (g) 5 h; or (h)  15 h. Lanes  (i-k) contained 
stoichiometric concentrations of ME (0.46/xg) and otlPI (1.75/xg) incubated for (i) 15 h with 30 mM 
EDTA, or incubated alone for (j) 0 h or (k) 0.5 h. Lane (1) contained ME alone (2 p,g). Electrophoresis 
conditions were identical to those in Fig. 1. H12E-otaPI indicates the position of the stable proteinase- 
inhibitor complex, otlPIi indicates the position of the degraded otlPI. 
specific active site-directed inhibitor of granulocyte elastase  (21),  was  preincubated 
with HGE before addition of c~IPI, no proteinase-inhibitor complex was formed. 
To test the effect of ME on HGE-c~IPI complexes, HGE was incubated with excess 
alPI  before  incubation  with  ME.  During  the  course  of incubation  (Fig.  4),  ME 
preferentially degraded the free alPI rather than the HGE-alPI complex. Only after 
apparently complete degradation of free aiPI was there any suggestion of ME cleavage 
of the  HGE-c~aPI  complex.  ME  did  not  release  any  detectable  HGE  elastinolytic 
activity from the HGE-alPI  complex. It is therefore unlikely that  ME  will interfere 
with the fate of proteinase-alPI complexes. 
Macrophage  elastase degraded atPI even  at  stoichiometric ratios. Comparison of 
reaction mixtures of alPI  and  ME  at  catalytic ratios  (Fig. 2)  and  at  stoichiometric 
ratios  (Fig.  4)  shows  similar  degradation  without  the  formation  of a  proteinase- 
inhibitor complex. 
Discussion 
The data presented here establish that a  metalloproteinase secreted by inflamma- 
tory mouse macrophages catalytically inactivates etlPI. This mechanism of destruction 
of ~tlPI  is independent  of the oxidative attenuation  of alPI by cigarette smoke, N- 
chlorosuccinimide, chloramine T, or the reactive oxygen species produced by phago- 
cytes in which the metabolic burst has been stimulated (8-11). The ability of ME to 
inactivate  axPI  may  be  an  important  consideration  when  evaluating  the  role  of 
inflammatory  macrophages  in  chronic  diseases  such  as  pulmonary  emphysema. 
Because the ratio of ME activity to granulocyte elastase activity in the lung is believed 
to be very low (25), the direct involvement of ME in elastinolysis during emphysema 
has  been  questioned.  However,  ~85%  of mouse  ME  is secreted in  an  inactive form 
(14,  15), and the activation of elastase would increase its involvement in elastinolysis. 1568  MACROPHAGE  ELASTASE INACTIVATES a~-PROTEINASE INHIBITOR 
Our  data suggest another role for the active ME  in connective tissue destruction. 
Because alPI inactivated by ME would no longer protect lung elastin from proteolytic 
degradation by granulocyte elastase, macrophages and active ME may play a pivotal 
role in lung pathology. 
The inhibition of ME by a2M is not likely to abrogate the potential physiologic 
importance of these findings. Although aIPI is plentiful in the lung, a2M has been 
detected only in trace quantities in lung lavage fluids (26). 
The inactivation of a~PI by other enzymes has been studied. Thiol proteinases such 
as cathepsin B (27) and papain (28) are not inhibited by aaPI. This characteristic of 
papain is likely to have been responsible for its favored use in animal model systems 
designed to study the development of emphysema (7, 29).  More recently, it has been 
shown that thiol proteinases mediate lung damage not only because they are resistant 
to alPI, but because they degrade it (30). 
Proteolytic inactivation of axPI  is  not  limited  to  thiol  proteinases.  The  culture 
supernates from Pseudomonas aeruginosa have also been shown to inactivate alPI (31). 
This activity has been attributed to the pseudomonal elastase (32), which is a neutral 
metalloproteinase. Other prokaryotic metalloproteinases have similarly been shown 
to inactivate alPI by degradation (32). It has also been demonstrated that eukaryotic 
metalloproteinases, such as those found in the venoms of Crotalidae, Viperidae, and 
Colubridae (33, 34) can degrade and inactivate alPI. 
Oxidation of reactive site methionyl residues in alPI (8, 9) and proteolytic cleavage 
of a~PI by bacterial proteinases  (31,  32)  have significant potential to mediate the 
degradation of lung elastin. Curiously, the degradation of alPI by cathepsin B occurs 
only at stoichiometric concentrations (30). If this observation is an accurate represen- 
tation  of cathepsin  B-alPI  inactivation  in  vivo,  cathepsin  B  is  unlikely to  be  an 
initiator of alPI inactivation. 
The ability to mediate lung degradation by both direct and indirect elastinolysis is 
not  unique  to  the  elastase  secreted  by  inflammatory macrophages.  Indeed,  the 
elastinolysis resulting from a P. aeruginosa pulmonary infection may be the result of 
both  the pseudomonal elastase activity and the unchecked activity of endogenous 
granulocyte proteinases (31, 32).  The inactivation of alPI by the metalloproteinases 
of that organism would disrupt the critical proteinase-inhibitor balance in the lungs 
and  permit  contributive  elastinolysis by  endogenous  granulocyte elastase  (9,  10). 
Because ME recognizes alPI as a substrate for proteolysis, inflammatory macrophages 
may  also  disrupt  the  proteinase-inhibitor  balance,  resulting  in  connective  tissue 
destruction.  The  two  organs,  liver  and  lung,  with  pathology  associated  with  an 
insufficiency of alPI have substantial populations of macrophages, and thus may be 
exquisitely sensitive to an imbalance of the serine proteinase:aaPI ratio. 
Summary 
Inflammatory mouse peritoneal  macrophages secrete a  metalloproteinase that  is 
not inhibited by al-proteinase inhibitor. This proteinase, macrophage elastase, rec- 
ognizes  al-proteinase  inhibitor  as  a  substrate  and  catalytically degrades  it.  The 
interaction of aa-proteinase inhibitor with macrophage elastase does not involve a 
stable proteinase-inhibitor complex and results in the proteolytic removal of a peptide 
of apparent molecular weight 4,000-5,000  from the inhibitor. After degradation by 
macrophage  elastase,  ax-proteinase  inhibitor  is  no  longer  able  to  inhibit  human MICHAEL J.  BANDA, ELIZABETH J.  CLARK, AND  ZENA WERB  1569 
granulocyte elastase, a serine proteinase implicated in the pathogenesis of emphysema. 
Macrophage  elastase  apparently  does  not  degrade  human  granulocyte elastase-ax- 
proteinase  inhibitor  complexes  or  release  active  granulocyte  elastase  from  these 
complexes.  The ability of macrophage elastase  to degrade al-proteinase  inhibitor  is 
inhibited by EDTA and a~-macroglobulin. 
Received  for publication 4 September 1980. 
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